What they were paid
UNITED THERAPEUTICS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $100,000 | $0 | $408,034 | $0 | $508,034 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: UNITED THERAPEUTICS Corp DEF 14A filed April 29, 2026, accession 0001082554-26-000009, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025UNITED THERAPEUTICS pays directors a $60,000 cash retainer and $400,000 in Stock Options or RSUs (director choice: 100% options, 100% RSUs, or 50/50).
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance (Chair)
The rest of the UNITED THERAPEUTICS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Christopher Patusky | Lead Independent Director | $541,312 |
| Jan Malcolm | Independent Director | $470,265 |
| Judy Olian | Independent Director | $476,397 |
| Linda Maxwell | Independent Director | $489,556 |
| Louis Sullivan | Independent Director | $499,127 |
| Martine Rothblatt | Director | $0 |
| Nilda Mesa | Independent Director | $493,743 |
| Ray Kurzweil | Independent Director | $463,743 |
| Raymond Dwek | Independent Director | $484,784 |
| Richard Giltner | Independent Director | $501,397 |
| Tommy Thompson | Independent Director | $483,034 |
The full UNITED THERAPEUTICS compensation record
free company briefThis page is one director within UNITED THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat